COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 1049: Articles 10481-10490  | Next

Healthcare worker risk of COVID-19: A 20-month analysis of protective measures from vaccination and beyond
Yassi, A., Barker, S., Lockhart, K., Grant, J. M., Okpani, A. I., Sprague, S., Zungu, M., Lubin, S., Kim Sing, C.
10.1101/2021.12.02.21267190 — Posted: 2021-12-05
Post-traumatic Stress Risk among COVID-19 Survivors in Colombia
Campo-Arias, A., Pedrozo-Pupo, J. C., Herazo, E.
10.1101/2021.12.02.21267210 — Posted: 2021-12-05
Worldwide routine immunisation coverage regressed during the first year of the COVID-19 pandemic
Evans, B., Jombart, T.
10.1101/2021.12.03.21267195 — Posted: 2021-12-05
Risk assessment of banknotes as a fomite of SARS-CoV-2 in cash payment transactions
Schijven, J., Wind, M., Todt, D., Howes, J., Tamele, B., Steinmann, E.
10.1101/2021.12.03.21267258 — Posted: 2021-12-05 Discussion: Onsite
Characteristics of Patients Referred to a Cardiovascular Disease Clinic for Post-Acute Sequelae of SARS-CoV-2 Infection
Wang, S. Y., Adejumo, P., See, C., Onuma, O. K., Miller, E. J., Spatz, E. S.
10.1101/2021.12.04.21267294 — Posted: 2021-12-05
Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with inactivated vaccine
Kanokudom, S., Assawakosri, S., Suntronwong, N., Auphimai, C., Nilyanimit, P., Vichaiwattana, P., Thongmee, T., Yorsaeng, R., Srimuan, D., Thatsanatorn, T., Klinfueng, S., Sudhinaraset, N., Wanlapakorn, N., Honsawek, S., Poovorawan, Y.
10.1101/2021.12.03.21267281 — Posted: 2021-12-05
Mucosal memory T cells in breastmilk are modulated by SARS-CoV-2 mRNA vaccination
Armistead, B., Jiang, Y., Carlson, M., Ford, E. S., Jani, S., Houck, J., Wu, X., Pecor, T., Kachikis, A., Yeung, W., Nguyen, T., Minkah, N., Larsen, S. E., Coler, R. N., Koelle, D. M., Harrington, W. E.
10.1101/2021.12.03.21267036 — Posted: 2021-12-05
Ad26.COV2.S or BNT162b2 Boosting of BNT162b2 Vaccinated Individuals
Tan, C. S., Collier, A.-r., Liu, J., Yu, J., Wan, H., McMahan, K., He, X., Jacob-Dolan, C., Chandrashekar, A., Sellers, D., Stephenson, K., Vidal, S., Jaegle, K., Curran, J., Rowe, M., Hemod, R., Bermudez Rivera, L., Anioke, T., Barrett, J., Chung, B., Gardner, S., Gebre, M., Lifton, M., Powers, O., VanWyk, H., Wu, C., Barouch, D.
10.1101/2021.12.02.21267198 — Posted: 2021-12-05 Discussion: Onsite
Comparison of different sequencing techniques with multiplex real-time PCR for detection to identify SARS-CoV-2 variants of concern
Ranasinghe, D., Jayadas, T., Jayathilaka, D., Jeewandara, C., Dissanayaka, O., Guruge, D., Ariyaratne, D., Gunasinghe, D., Gomes, L., Wijesinghe, A., Wijayamuni, R., Malavige, G. N.
10.1101/2021.12.05.21267303 — Posted: 2021-12-05
S glycoprotein diversity of the Omicron Variant
Sarkar, R., Lo, M., Saha, R., Dutta, S., Chawla-Sarkar, M.
10.1101/2021.12.04.21267284 — Posted: 2021-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).